Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. 2012

Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 80045, USA. Joshua.Thurman@ucdenver.edu

The complement cascade is an important part of the innate immune system, but pathological activation of this system causes tissue injury in several autoimmune and inflammatory diseases, including immune complex glomerulonephritis. We examined whether mice with targeted deletion of the gene for factor B (fB(-/-) mice) and selective deficiency in the alternative pathway of complement are protected from injury in the nephrotoxic serum (NTS) nephritis model of antibody-mediated glomerulonephritis. When the acute affects of the anti-glomerular basement membrane antibody were assessed, fB(-/-) mice developed a degree of injury similar to wild-type controls. If the mice were presensitized with sheep IgG or if the mice were followed for 5 mo postinjection, however, the fB(-/-) mice developed milder injury than wild-type mice. The immune response of fB(-/-) mice exposed to sheep IgG was similar to that of wild-type mice, but the fB(-/-) mice had less glomerular C3 deposition and lower levels of albuminuria. These results demonstrate that fB(-/-) mice are not significantly protected from acute heterologous injury in NTS nephritis but are protected from autologous injury in response to a planted glomerular antigen. Thus, although the glomerulus is resistant to antibody-initiated, alternative pathway-mediated injury, inhibition of this complement pathway may be beneficial in chronic immune complex-mediated diseases.

UI MeSH Term Description Entries
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D011415 Complement Factor B A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb. C3 Proactivator,C3PA,Complement 3 Proactivator,Factor B,Properdin Factor B,Bb Fragment of Factor B,Complement Factor B Fragment, Bb,Complement Factor B, Alternative Pathway,Complement Factor B-Derived Fragment Bb,Complement Factor Ba,Complement Factor Bb,Complement Protein B,Complement Protein Factor B,Properdin Factor Ba,Properdin Factor Bb,Properdin Factor Bf,Properdin Factor Bf F1,Bb, Complement Factor,Complement Factor B Derived Fragment Bb,Factor B, Complement,Factor B, Properdin,Factor Ba, Complement,Factor Ba, Properdin,Factor Bb, Complement,Factor Bb, Properdin,Factor Bf, Properdin,Proactivator, C3,Proactivator, Complement 3,Protein B, Complement
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out

Related Publications

Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
April 1977, Clinical and experimental immunology,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
May 1965, The Journal of experimental medicine,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
January 1991, Nephron,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
June 1976, Clinical and experimental immunology,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
March 1967, Journal of immunology (Baltimore, Md. : 1950),
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
April 1979, Clinical and experimental immunology,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
November 1982, Acta pathologica japonica,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
June 2021, Clinical rheumatology,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
October 1975, Clinical and experimental immunology,
Joshua M Thurman, and Svetlana N Tchepeleva, and Mark Haas, and Sarah Panzer, and Susan A Boackle, and Magdalena J Glogowska, and Richard J Quigg, and V Michael Holers
October 1963, Nature,
Copied contents to your clipboard!